Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-083664
Filing Date
2026-07-31
Accepted
2026-07-31 09:11:01
Documents
3
Period of Report
2026-07-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0300034-6k_newcelx.htm 6-K 12418
2 PRESS RELEASE TITLED: "NEWCELX ANNOUNCES PRICING OF $1.4 MILLION EQUITY FINANCIN ea030003402ex99-1.htm EX-99.1 13327
3 GRAPHIC ea030003402_ex99-1img1.jpg GRAPHIC 9174
  Complete submission text file 0001213900-26-083664.txt   39736
Mailing Address THE CIRCLE 6 8058 ZURICH Switzerland
Business Address THE CIRCLE 6 8058 ZURICH Switzerland 41-41-618-80-00
NewcelX Ltd. (Filer) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 261225652
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)